This Article Full Text Full Text (PDF) All Versions of this Article: 21/7/1499    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Silva, C. M. Articles by Shupnik, M. A. Search for Related Content PubMed PubMed Citation Articles by Silva, C. M. Articles by Shupnik, M. A.

Integration of Steroid and Growth Factor Pathways in Breast Cancer: Focus on Signal Transducers and Activators of Transcription and Their Potential Role in Resistance

Departments of Medicine, Microbiology (C.M.S.), Physiology (M.A.S.) and the Cancer Center, University of Virginia Health System, Charlottesville, Virginia 22908

Address all correspondence and requests for reprints to: Corinne M. Silva, Department of Medicine, PO Box 800578, University of Virginia Health System, Charlottesville, Virginia 22908. E-mail: cms3e{at}virginia.edu.

The signaling pathways that are critical to the development and growth of breast cancer include those activated downstream of the estrogen receptor (ER) and the human epidermal growth factor receptor family. Many of these pathways, including the signal transducer and activator of transcription pathway, are common to both. The well-described genomic actions of ER involve its role as a transcription factor, either by binding directly to DNA through estrogen response elements, or by tethering to DNA through interaction with other proteins. Nongenomic signaling by the ER involves interaction with membrane-associated signaling proteins such as the c-Src tyrosine kinase and adapter proteins p130Cas and moderator of nongenomic activity of ER. Interactions with the signal transducer and activator of transcription pathway are important in both ER signaling pathways and are critical for estrogen-induced proliferation and tumorigenesis. These mechanisms of signaling cross talk and their role in resistance to antiestrogen therapies are discussed.

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα  |  ERβ  |  PR  |  AR

Coregulators:   BRCA1  |  CBP  |  p300  |  SRC-1  |  PELP1  |  AIB1  |  NCOR  |  SMRT

Ligands:   17β-Estradiol  |  Progesterone  |  Raloxifene  |  Mifepristone  |  Fulvestrant

This article has been cited by other articles:

				E. M. Fox, T. M. Bernaciak, J. Wen, A. M. Weaver, M. A. Shupnik, and C. M. Silva Signal Transducer and Activator of Transcription 5b, c-Src, and Epidermal Growth Factor Receptor Signaling Play Integral Roles in Estrogen-Stimulated Proliferation of Estrogen Receptor-Positive Breast Cancer Cells Mol. Endocrinol., August 1, 2008; 22(8): 1781 - 1796. [Abstract] [Full Text] [PDF]

				B. Dong and F. Matsumura Roles of Cytosolic Phospholipase A2 and Src Kinase in the Early Action of 2,3,7,8-Tetrachlorodibenzo-p-dioxin through a Nongenomic Pathway in MCF10A Cells Mol. Pharmacol., July 1, 2008; 74(1): 255 - 263. [Abstract] [Full Text] [PDF]

				A. Pattarozzi, M. Gatti, F. Barbieri, R. Wurth, C. Porcile, G. Lunardi, A. Ratto, R. Favoni, A. Bajetto, A. Ferrari, et al. 17 -Estradiol Promotes Breast Cancer Cell Proliferation-Inducing Stromal Cell-Derived Factor-1-Mediated Epidermal Growth Factor Receptor Transactivation: Reversal by Gefitinib Pretreatment Mol. Pharmacol., January 1, 2008; 73(1): 191 - 202. [Abstract] [Full Text] [PDF]